AU2012348569B2 - Use of silver (I) complexes as anticancer agents - Google Patents

Use of silver (I) complexes as anticancer agents Download PDF

Info

Publication number
AU2012348569B2
AU2012348569B2 AU2012348569A AU2012348569A AU2012348569B2 AU 2012348569 B2 AU2012348569 B2 AU 2012348569B2 AU 2012348569 A AU2012348569 A AU 2012348569A AU 2012348569 A AU2012348569 A AU 2012348569A AU 2012348569 B2 AU2012348569 B2 AU 2012348569B2
Authority
AU
Australia
Prior art keywords
cancer
cells
silver
complexes
moieties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012348569A
Other languages
English (en)
Other versions
AU2012348569A1 (en
Inventor
Marianne Jacqueline Cronje
Reinout MEIJBOOM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Johannesburg
Original Assignee
University of Johannesburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Johannesburg filed Critical University of Johannesburg
Publication of AU2012348569A1 publication Critical patent/AU2012348569A1/en
Application granted granted Critical
Publication of AU2012348569B2 publication Critical patent/AU2012348569B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2012348569A 2011-12-06 2012-12-06 Use of silver (I) complexes as anticancer agents Ceased AU2012348569B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA2011/08944 2011-12-06
ZA201108944 2011-12-06
PCT/IB2012/057029 WO2013084185A1 (en) 2011-12-06 2012-12-06 Use of silver (i) complexes as anticancer agents

Publications (2)

Publication Number Publication Date
AU2012348569A1 AU2012348569A1 (en) 2014-07-03
AU2012348569B2 true AU2012348569B2 (en) 2016-09-01

Family

ID=47557421

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012348569A Ceased AU2012348569B2 (en) 2011-12-06 2012-12-06 Use of silver (I) complexes as anticancer agents

Country Status (7)

Country Link
US (2) US9676801B2 (enExample)
EP (1) EP2788007B1 (enExample)
AU (1) AU2012348569B2 (enExample)
CA (1) CA2858325C (enExample)
IN (1) IN2014DN04596A (enExample)
WO (1) WO2013084185A1 (enExample)
ZA (1) ZA201404068B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109705158B (zh) * 2019-01-14 2021-01-05 温州大学新材料与产业技术研究院 一种独立双中心Ag配合物及其制备方法和抗癌活性评价
CN110028526B (zh) * 2019-05-20 2021-07-13 福州大学 高水稳定性兼具蓝绿色发射光及光电响应性能的无机有机杂化材料
CN110041364A (zh) * 2019-05-28 2019-07-23 福建医科大学附属协和医院 一种兼具蓝绿光发光、抗菌和光电响应的高水稳定性无机有机多功能杂化材料
BR102019022373A2 (pt) * 2019-10-24 2021-05-04 Universidade Estadual De Campinas - Unicamp processo de obtenção dos dispositivos de cb-ag-nms e cb-ag-paba, dispositivos de cb-ag-nms e cb-ag-paba e uso dos dispositivos cb-ag-nms e cb-ag-paba

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372313A2 (de) * 1988-12-02 1990-06-13 Hoechst Aktiengesellschaft Sulfonierte Phenylphosphane enthaltende Komplexverbindungen
WO2011089780A1 (ja) * 2010-01-19 2011-07-28 セントラル硝子株式会社 トリアルキルホスフィンの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857549A (en) * 1984-02-01 1989-08-15 Smithkline Beckman Corporation Antitumor compounds
KR100772790B1 (ko) 2002-04-30 2007-11-01 삼성전자주식회사 금속 패턴 형성용 유기금속 전구체 및 이를 이용한 금속패턴 형성방법
GB0900961D0 (en) * 2009-01-20 2009-03-04 Univ Bath Antimicrobial coating

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372313A2 (de) * 1988-12-02 1990-06-13 Hoechst Aktiengesellschaft Sulfonierte Phenylphosphane enthaltende Komplexverbindungen
WO2011089780A1 (ja) * 2010-01-19 2011-07-28 セントラル硝子株式会社 トリアルキルホスフィンの製造方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KYROS, L. et al., Bioinorganic Chemistry and Applications. 2010, Article ID 386860, pages 1-12 *
POYRAZ, M. et al., Inorganica Chimica Acta. April 2011, vol. 375, no. 1, pages 114-121 *
ZARTILAS, S. et al., Inorganica Chimica Acta. 2009, vol. 362, no. 3, pages 1003-1010 *

Also Published As

Publication number Publication date
IN2014DN04596A (enExample) 2015-05-08
EP2788007B1 (en) 2020-09-02
EP2788007A1 (en) 2014-10-15
AU2012348569A1 (en) 2014-07-03
US20150037256A1 (en) 2015-02-05
US9676801B2 (en) 2017-06-13
US10583109B2 (en) 2020-03-10
CA2858325C (en) 2018-03-13
US20170239208A1 (en) 2017-08-24
ZA201404068B (en) 2015-04-29
WO2013084185A1 (en) 2013-06-13
CA2858325A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
Chen et al. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells
Pisano et al. Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways
Li et al. Autophagy modulation in bladder cancer development and treatment
Tisato et al. Copper in diseases and treatments, and copper‐based anticancer strategies
Gao et al. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway
Ganapathy-Kanniappan et al. 3-Bromopyruvate induces endoplasmic reticulum stress, overcomes autophagy and causes apoptosis in human HCC cell lines
US10583109B2 (en) Use of silver(I) complexes as anticancer agents
Misirlic Dencic et al. Cyclohexyl analogues of ethylenediamine dipropanoic acid induce caspase-independent mitochondrial apoptosis in human leukemic cells
Nie et al. Reduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803
Hung et al. Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancer
Pandey et al. Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway
Human et al. The induction of cell death by phosphine silver (I) thiocyanate complexes in SNO-esophageal cancer cells
Chan et al. Cytotoxicity of bismuth (III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion
Ma et al. A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen
Guo et al. Insights into anticancer activity and mechanism of action of a ruthenium (II) complex in human esophageal squamous carcinoma EC109 cells
Jiang et al. Design of a novel Pt (ii) complex to reverse cisplatin-induced resistance in lung cancer via a multi-mechanism
Nandha et al. Targeting mitochondrial proteases CLPP and LONP1 via disruption of mitochondrial redox homeostasis induces proteotoxic stress and suppresses tumor progression
Chen et al. Autophagy induced by proteasomal DUB inhibitor NiPT restricts NiPT-mediated cancer cell death
Čižauskaitė et al. Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells
Hashemi et al. Prostate Cancer, Apoptosis, Autophagy and Ferroptosis: Cell Death Mechanisms and Their Cross-talk
Vargas-Ramírez et al. N-ω-chloroacetyl-L-ornithine has in-vitro activity against cancer cell lines and in-vivo activity against ascitic and solid tumors
Zhao et al. Antitumor activity of selenium modification of the bovine milk component β-Lg (Se-β-Lg) on H22 cells
Isakovic et al. In vitro and in vivo antimelanoma effect of ethyl ester cyclohexyl analog of ethylenediamine dipropanoic acid
Mathuram et al. Correlative studies unravelling the possible mechanism of cell death in tideglusib-treated human ovarian teratocarcinoma-derived PA-1 cells
Nosálová et al. Newly synthesized pyrrolidine analog SS13 induces extrinsic and intrinsic apoptotic pathways in colorectal cancer cells

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired